I treat people not diseases. Everyone has unique perspectives, priorities, strengths and weaknesses that are important to understand in working towards their health goals. Good communication is critical to this relationship, especially my ability to really hear patients and to communicate my thoughts in a way that is understandable. I am open to admitting when I don’t have the answers and enjoy working with a team of other clinicians.
In my spare time I enjoy dance of all kinds, history, & hiking in the beautiful Colorado mountains.
Qualifications and experience
- Brain and Nervous System, Brain and Nervous System - Deep Brain Stimulation, Brain and Nervous System - Movement Disorders, Brain and Nervous System - Parkinson's Disease, Neurology
- Languages spoken
University of Colorado (1993)
St Luke's Hospital Program (1987)
University of Texas Medical School at Houston (1986)
University of Colorado (University Hospital) Program (1990)
University of Texas Health Science Center at Houston (TX) (1977)
- Clinical interest for patients
Dr. Leehey is a Professor of Neurology and Chief of the Movement Disorders Division at the University of Colorado Denver and a Fellow Member of the American Academy of Neurology. She specializes in movement disorders and Fragile X associated disorders and sub-specializes in movement disorders and Botox therapy. She sees patients at the University of Colorado Hospital Anschutz Centers for Advanced Medicine. She is board certified in Neurology and Psychiatry, and is a fellowship-trained movement disorders specialist. She is the senior movement disorders neurologist in the Rocky Mountain region and has mentored numerous neurologists. During her 29 years at the University of Colorado, she has managed thousands of patients with Parkinson's disease, is Lead Investigator in the International Parkinson Disease Study Group, and has been the Primary Investigator for over 20 Parkinson's disease clinical trials.
- Research interest for patients
My research is focused on Parkinson's disease, CBD/medical marijuana, and Fragile X disorders.